Adcom Outcome For Lipcocine's Testosterone Drug Punctures Stock; Canaccord Downgrades
January 11, 2018 at 14:49 PM EST
Lipocine Inc (NASDAQ: LPCN), a pharma company focusing on men's and women's health, announced Wednesday the FDA's Bone, ...